Posted by Elucigene on 26th Oct 2016<\/p>\n
<\/p>\n
Elucigene Diagnostics, developer and distributor of leading prenatal and human genetics diagnostics and LifeCodexx AG, pioneer in cell-free fetal DNA testing in Europe, announced today (26th October 2016) that they have partnered. Through this cooperation, UK and Irish patients will have access to LifeCodexx\u2019 proprietary PrenaTest®<\/sup> NIPT technology.<\/p>\n <\/p>\n PrenaTest®<\/sup> was Europe\u2019s first non-invasive prenatal test (NIPT), significantly enhancing prenatal trisomy screening sensitivity, whilst drastically reducing invasive procedure linked pregnancy loss occurrence. The test is performed within Germany in strict conformity with the highest quality standards as per the European Directive on In-vitro Diagnostic Medical Devices. Currently, every 30 minutes a pregnant woman opts for PrenaTest®<\/sup> being a leading NIPT across Europe and the Middle East.<\/p>\n <\/p>\n Dr. Mark Street-Docherty, Commercial Manager of Elucigene Diagnostics says \u201cWe are delighted to be able to offer pregnant women across the UK access to leading NIPT technology, ensuring safe and accurate screening for the most common chromosomal trisomies. This service complements our continued support for prenatal testing accuracy, alongside our leading QST*R diagnostic prenatal range\u201d.<\/p>\n <\/p>\n \u201cWe are very pleased to add Elucigene Diagnostics to our group of partners with their long standing expertise in the field of prenatal diagnostic in the U.K but also elsewhere,\u201d added Dr. Michael Lutz, CEO of LifeCodexx. \u201cWith this new partnership, our high quality PrenaTest®<\/sup> is now available in more than 40 countries throughout Europe and the Middle East.\u201d<\/p>\n PrenaTest®<\/sup> will be offered through the partnership with immediate effect, and interested patients and clinics should contact enquiries@elucigene.com<\/a> for more detailed information.<\/p>\n","protected":false},"excerpt":{"rendered":" Elucigene Diagnostics, developer and distributor of leading prenatal and human genetics diagnostics and LifeCodexx AG, pioneer in cell-free fetal DNA testing in Europe, announced today (26th October 2016) that they have partnered. Through this cooperation, UK and Irish patients will have access to LifeCodexx\u2019 proprietary PrenaTest\u00ae NIPT technology.
… read more<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"ghostkit_customizer_options":"","ghostkit_custom_css":"","ghostkit_custom_js_head":"","ghostkit_custom_js_foot":"","ghostkit_typography":""},"categories":[],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.praenaforyou.com\/en\/wp-json\/wp\/v2\/posts\/117"}],"collection":[{"href":"https:\/\/www.praenaforyou.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.praenaforyou.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.praenaforyou.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.praenaforyou.com\/en\/wp-json\/wp\/v2\/comments?post=117"}],"version-history":[{"count":0,"href":"https:\/\/www.praenaforyou.com\/en\/wp-json\/wp\/v2\/posts\/117\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.praenaforyou.com\/en\/wp-json\/wp\/v2\/media?parent=117"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.praenaforyou.com\/en\/wp-json\/wp\/v2\/categories?post=117"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.praenaforyou.com\/en\/wp-json\/wp\/v2\/tags?post=117"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}